Policy · FAQ · AEO
Is ibogaine legal if my state funds research? Schedule I vs state bills
LAST REVIEWED 2026-09-22 · EDUCATIONAL · NOT LEGAL ADVICE
Short answers for a common confusion: federal controlled-substance scheduling, state research/funding bills, and FDA approval are different layers. This page tracks facts only — not advice to seek treatment, travel, or source substances.
What is the U.S. federal status of ibogaine?
Ibogaine is listed in Schedule I under federal controlled-substances regulations (21 CFR 1308.11). Primary text: 21 CFR 1308.11 (Cornell LII).
Do state ibogaine bills override Schedule I?
Not by default. State research appropriations, study committees, pilot-program frameworks, and clinical-trial funding create state policy and research pathways. They do not automatically erase federal controlled-substance law. Tracker hub: Policy and law.
- Texas SB 2308 research program / UTMB award context — policy desk and Perry/Hubbard LL extract.
- Kentucky proposal history (withdrawn settlement plan) — same policy desk.
Has the FDA approved ibogaine or noribogaine?
No — neither ibogaine nor noribogaine is an FDA-approved drug treatment on this review date. Allowing an investigational study to proceed is not marketing approval. Full claim check: “FDA allowed noribogaine, so it is approved”. FDA announcement: FDA press announcement.
What state bills are not
- Not proof that ibogaine works or is safe.
- Not a clinic referral list (IbogaBase does not refer).
- Not permission for unsupervised / DIY use — DIY refusal.
- Not a substitute for reading current primary law with qualified counsel.